Osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells after thawing in culture

被引:14
作者
Hirose, M
Kotobuki, N
Machida, H
Kitamura, S
Ohgushi, H
Tateishi, T
机构
[1] AIST, TERC, Amagasaki, Hyogo 6610974, Japan
[2] Univ Tokyo, Grad Sch Engn, Biomed Engn Lab, Bunkyo Ku, Tokyo 1138656, Japan
来源
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS | 2004年 / 24卷 / 03期
关键词
cryopreservation; bone marrow; cell viability; mineralization; tissue engineering;
D O I
10.1016/j.msec.2003.12.011
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Cryopreserved human bone marrow-derived mesenchymal cells (hBMCs) were thawed and replated in culture dishes. Viability of the cells immediately after thawing was 98%. When the cells were cultured in the presence or absence of dexamethasone, the cells proliferated to reach confluency at culture day 7. The cells treated with dexamethasone formed abundant mineralized nodules at their extracellular regions after about culture day 14, while the cultures without dexamethasone did not exhibit bone fort-nation. The calcein uptake into the extracellular matrix layer was detected in the dexamethasone-treated cells with the increase in fluorescent intensity with culture periods but not in the nontreated cells. These results suggest that human bone marrow-derived mesenchymal cells retain bone-forming capability even after cryopreservation/thawing. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:355 / 359
页数:5
相关论文
共 14 条
[1]  
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[2]  
2-F
[3]   Quantitative monitoring of in vitro mineralization process using fluorescent dyes [J].
Hirose, M ;
Kotobuki, N ;
Machida, H ;
Uchimura, E ;
Ohgushi, H .
BIOCERAMICS 15, 2003, 240-2 :715-717
[4]  
Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO
[5]  
2-S
[6]  
Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO
[7]  
2-0
[8]  
Ohgushi H, 1999, J BIOMED MATER RES, V44, P381, DOI 10.1002/(SICI)1097-4636(19990315)44:4<381::AID-JBM3>3.0.CO
[9]  
2-E
[10]  
Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO